Teva launches of a generic version of Uceris in the United States
JERUSALEM — Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Uceris (budesonide) extended-release tablets, 9 mg, in the U.S. Budesonide extended-release tablets are a glucocorticosteroid indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. “The launch of generic budesonide extended-release tablets signals an important
